Pharmaceutical & Biotech
South Korea's Yuhan Chemical Expands APIs CDMO Business
Yuhan Corporation (Seoul) is expanding its active pharmaceutical ingredient (API) contract development and manufacturing organization (CDMO) business through its subsidiary Yuhan Chemical
Released Wednesday, August 21, 2024
Reports related to this article:
Project(s): View 1 related project in PECWeb
Plant(s): View 1 related plant in PECWeb
Researched by Industrial Info Resources (Sugar Land, Texas)--Yuhan Corporation (Seoul) is expanding its active pharmaceutical ingredient (API) contract development and manufacturing organization (CDMO) business through its subsidiary Yuhan Chemical.
After building a new production building (HB building) at its Hwaseong plant in November last year, Yuhan Chemical has been working on the 19.7 billion-won (US$14.7 million) BAY-2 construction in the HB building since the end of last year.
With the goal of completion in December, it is expected to begin full-scale commercial production in March of next year after going through procedures such as commissioning.
Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical-Biotech Industry Project Database can click here to read the detailed project report.
Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking over 200,000 current and future projects worth $17.8 Trillion (USD).
/news/article.jsp
false
Want More IIR News Intelligence?
Make us a Preferred Source on Google to see more of us when you search.
Add Us On GoogleAsk Us
Have a question for our staff?
Submit a question and one of our experts will be happy to assist you.
Forecasts & Analytical Solutions
Where global project and asset data meets advanced analytics for smarter market sizing and forecasting.
Explore Our SolutionsRelated Articles
-
Two South Korean Pharma Companies Set Up R&D CentersSeptember 29, 2023
-
South Korea's PharmaBio Companies Increase R&D SpendOctober 25, 2022
-
Research Labs Spring Up Across U.S.May 20, 2026
Industrial Project Opportunity Database and Project Leads
Get access to verified capital and maintenance project leads to power your growth.
Discover Our DatabaseIndustry Intel
-
2026-2027 Investment Radar for Mexico, Central America & the CaribbeanPodcast Episode / May 29, 2026
-
Innovations Shaping the Next Era of Power GenerationPodcast Episode / May 22, 2026
-
The Role of Contract Manufacturing in Global Pharma GrowthPodcast Episode / May 8, 2026
-
2026 North American Labor OutlookPodcast Episode / Apr 24, 2026
-
2026 European Metals & Minerals Project Spending OutlookPodcast Episode / Apr 7, 2026